Tong Ren Tang Technologies Co. Ltd.

HKSE 1666.HK

Tong Ren Tang Technologies Co. Ltd. Receivables for the year ending December 31, 2023: USD 118.18 M

Tong Ren Tang Technologies Co. Ltd. Receivables is USD 118.18 M for the year ending December 31, 2023, a 0.00% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Tong Ren Tang Technologies Co. Ltd. Receivables for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
  • Tong Ren Tang Technologies Co. Ltd. Receivables for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
  • Tong Ren Tang Technologies Co. Ltd. Receivables for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
  • Tong Ren Tang Technologies Co. Ltd. Receivables for the year ending December 31, 2019 was USD 0.00, a -100.00% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
Loading...
SV Wall Street
HKSE: 1666.HK

Tong Ren Tang Technologies Co. Ltd.

CEO Mr. Jia Fu Chen
IPO Date Oct. 31, 2000
Location China
Headquarters No. 20 Nansanhuan Zhonglu Road
Employees 4,005
Sector Health Care
Industries
Description

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.

Similar companies

2005.HK

SSY Group Limited

USD 0.41

0.30%

1681.HK

Consun Pharmaceutical Group Limited

USD 1.00

-0.65%

1515.HK

China Resources Medical Holdings Company Limited

USD 0.49

1.59%

1513.HK

Livzon Pharmaceutical Group Inc.

USD 3.40

1.52%

StockViz Staff

January 31, 2025

Any question? Send us an email